Reduced incidence of insect-bite hypersensitivity in Icelandic horses is associated with a down-regulation of interleukin-4 by interleukin-10 and transforming growth factor-β1

被引:27
|
作者
Hamza, Eman [1 ]
Wagner, Bettina [2 ]
Jungi, Thomas W. [1 ]
Mirkovitch, Jelena [1 ]
Marti, Eliane [3 ]
机构
[1] Univ Bern, Vetsuisse Fac, Inst Vet Virol, CH-3001 Bern, Switzerland
[2] Cornell Univ, New York State Coll Vet Med, James A Baker Inst Anim Hlth, Ithaca, NY 14853 USA
[3] Univ Bern, Vetsuisse Fac, Dept Clin Vet Med, CH-3001 Bern, Switzerland
关键词
Icelandic horses; insect-bite hypersensitivity; interleukin-4; interleukin-10; transforming growth factor-beta; allergy; immediate-type hypersensitivity;
D O I
10.1016/j.vetimm.2007.10.018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Insect bite hypersensitivity (IBH) is an allergic dermatitis of horses caused by IgE-mediated reactions to bites of insects of the genus Culicoides. IBH does not occur in Iceland due to the absence of Culicoides. However, Icelandic horses exported to mainland Europe as adults (1st generation) have a >= 50% incidence of developing IBH. In contrast, their progeny (2nd generation) has a < 10% incidence of IBH. Here we show that peripheral blood mononuclear cells (PBMC) from Icelandic horses born in mainland Europe and belonging either to the IBH or healthy subgroup produce less interleukin (IL)-4 after polyclonal or allergen-specific stimulation when compared with counterparts from horses born in Iceland. We examined a role of IL-10 and transforming growth factor (TGF)-beta 1 in down-regulation of IL-4 in healthy 2nd generation Icelandic horses. Supernatants of PBMC from 2nd generation healthy horses down-regulated the proportion of IL-4-producing cells and IL-4 production in stimulated cultures of PBMC from 1st generation IBH. This inhibition was mimicked by a combination of IL-10 and TGF-beta 1 but not by the single cytokines. Cultures of stimulated PBMC of healthy 2nd generation horses produced a low level of IL-4, but IL-4 production was increased by anti-equine IL-10 and anti-human TGF-beta 1. This shows for the first time that in horses, IL-10 and TGF-beta 1 combined regulate IL-4 production in vitro. It is suggested that in this naturally occurring IgE-mediated allergy, IL-10 and TGF-beta 1 have a role in the down-regulation of IL-4-induced allergen-specific Th2 cells, thereby reducing the incidence of IBH. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:65 / 75
页数:11
相关论文
共 20 条
  • [1] Anti-inflammatory effects of interleukin-4 interleukin-10, and transforming growth factor-β on human placental cells in vitro
    Goodwin, VJ
    Sato, TA
    Mitchell, MD
    Keelan, JA
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1998, 40 (05): : 319 - 325
  • [2] ]Down-regulation of transforming growth factor-β and interleukin-10 secretion from malignant glioma cells by cytokines and anticancer drugs
    Naganuma, H
    Sasaki, A
    Satoh, E
    Nagasaka, M
    Nakano, S
    Isoe, S
    Nukui, H
    JOURNAL OF NEURO-ONCOLOGY, 1998, 39 (03) : 227 - 236
  • [3] Down-regulation of transforming growth factor-β and interleukin-10 secretion from malignant glioma cells by cytokines and anticancer drugs
    Hirofumi Naganuma
    Atsushi Sasaki
    Eiji Satoh
    Mitsuyasu Nagasaka
    Shin Nakano
    Shiro Isoe
    Hideaki Nukui
    Journal of Neuro-Oncology, 1998, 39 (3) : 229 - 236
  • [4] TRANSFORMING GROWTH-FACTOR-BETA AND INTERLEUKIN-10, BUT NOT INTERLEUKIN-4, DOWN-REGULATE PROCOAGULANT ACTIVITY AND TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTE-DERIVED MACROPHAGES
    JUNGI, TW
    BRCIC, M
    EPERON, S
    ALBRECHT, S
    THROMBOSIS RESEARCH, 1994, 76 (05) : 463 - 474
  • [5] Down-regulation of tumor necrosis factor-α, moderate reduction of interleukin-1β, but not interleukin-6 or interleukin-10, by glucan immunomodulators curdlan sulfate and lentinan
    Masihi, KN
    Madaj, K
    Hintelmann, H
    Gast, G
    Kaneko, Y
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1997, 19 (9-10): : 463 - 468
  • [6] Transforming growth factor-β1 and interleukin-10 in breast milk and development of atopic diseases in infants
    Rigotti, E
    Piacentini, GL
    Ress, M
    Pigozzi, R
    Boner, AL
    Peroni, DG
    CLINICAL AND EXPERIMENTAL ALLERGY, 2006, 36 (05) : 614 - 618
  • [7] Interleukin-10 and transforming growth factor-β1 in cord blood: relationship with paternal allergy and cesarean section
    Balossini, V.
    Monzani, A.
    Rapa, A.
    Vivenza, D.
    Caristo, E.
    Oderda, G.
    ACTA PAEDIATRICA, 2009, 98 (05) : 812 - 816
  • [8] Effect of dexamethasone on the release of transforming growth factor-β1, interleukin-8, interleukin-10 and RANTES release by sputum cells in severe asthma
    Gai Xiao-yan
    Sun Yong-chang
    Cao Wen-li
    CHINESE MEDICAL JOURNAL, 2006, 119 (18) : 1567 - 1571
  • [9] Adalimumab and methotrexate affect the concentrations of regulatory cytokines (interleukin-10, transforming growth factor-β1, and interleukin-35) in patients with plaque psoriasis
    Zdanowska, Natalia
    Owczarczyk-Saczonek, Agnieszka
    Czerwinska, Joanna
    Nowakowski, Jacek J.
    Kozera-Zywczyk, Anna
    Owczarek, Witold
    Zdanowski, Wojciech
    Placek, Waldemar
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [10] Oral tolerance induced by continuous feeding:: enhanced up-regulation of transforming growth factor-β/interleukin-10 and suppression of experimental autoimmune encephalomyelitis
    Faria, AMC
    Maron, R
    Ficker, SM
    Slavin, AJ
    Spahn, T
    Weiner, HL
    JOURNAL OF AUTOIMMUNITY, 2003, 20 (02) : 135 - 145